With Heart Failure been identified as one of the major cardiac disorders with increasing prevalence in India and globally. As an effort to curb the disease in the city, Dr. Prabhu Halkatti, Head, Department of Cardiology and Senior Intervention Cardiologist, KLES Hospital and Dr. Suresh Patted, Senior Intervention Cardiologist, KLES hospital recently conducted a breakthrough surgery with the implant of a technologically advanced defibrillator medically known as “PROTECTA” an Implantable Cardioverter Defibrillator for the management of irregular heartbeats. Dr. Prabhu Halkatti is the first intervention cardiologist to implant this new technology in Karnataka.
Sagar(Name Changed) aged 57 was suffering from hypertension and Heart Failure (restricted blood flow to the heart muscle) for the past three years. Due to this he was under a constant risk of falling prey to an episode of Sudden Cardiac Arrest. He was undergoing treatment for the past two years leading to frequent hospitalization to monitor and manage the fluid accumulation in his heart.
Doctors at KLES hospital who advised Sagar to undergo an ICD implant and is now leading a stress-free life post surgery.
Heart failure is a disease in which the heart pumping capacity reduces significantly due to either progressive fluid accumulation/congestion in the heart or inadequate blood flow to tissues. An implantable-cardioverter defibrillator (ICD) is commonly recommended for the management of heart failure that uses electrical impulses to stop fatal heart rhythms complemented by a fluid monitoring system.
While an ICD detects an irregular rhythm and sends low-energy electrical pulses to normalize the heartbeat, a Fluid monitoring system monitors the Fluid volume overload (congestion) in patients with moderate-to-severe Heart Failure leading to frequent hospital readmissions.
Majority of the shocks delivered by an ICD are necessary to treat potentially fatal arrhythmias (irregular heart beat). Contrary to the traditional ICD devices, Medtronic’s PROTECTA device is designed to recognize heart arrhythmias and noise through its “SmartShock™ Technology” to deliver therapeutic shocks only when required. This “SmartShock™ Technology” includes six Medtronic-exclusive algorithms backed by extensive clinical research.
“With these new devices, I can provide my patients with lifesaving technology that provides them peace of mind that they can maintain an active lifestyle since their severe heart condition is under control and they will receive life-saving therapy only when needed. This device is a boon to heart failure patients and has made a remarkable improvement in the quality of life of Mr. Sagar,” said Dr. Prabhu Halkatti of KLES Heart Foundation.
“The Protecta family of devices addresses one of the most critical unmet physician needs also reduces the economic burden of the patient and their family while also reducing the mental trauma of undergoing regular hospital visits.” said Dr. Prabhu Halkatti.
Dr. Prabhakar Kore, Chairmen of KLES hospital and MRC, Medical director Dr. M.R. Jali and Dr. D.M. Dixit, Director of heart foundation have appreciated and congratulated Dr. Prabhu Halkatti and Dr. Suresh Patted for changing life of the patients by implanting such world class devices in Belgaum.